Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in SPRB — Spruce Biosciences, Inc.

CIK 1390777 NEW YORK, NY
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$366,066
+$164,655 QoQ
Shares Held
6,779
+42268.8% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 63 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. SPRB ranks #264 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in SPRB

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $366,066 6,779
2023-09-30 $201,411 89,120
2023-06-30 $196,628 91,455
2023-03-31 $203,490 92,077
2022-12-31 $101,008 92,077
2022-09-30 $127,086 92,764
2022-06-30 $161,409 92,764
2022-03-31 $234,166 116,501
2021-12-31 $124,402 27,893
2021-09-30 $164,961 27,448
2021-06-30 $286,594 25,566
2021-03-31 $318,387 19,180
2020-12-31 $327,989 13,492